Document Detail

Collateralization and ischemia in hemodynamic cerebrovascular insufficiency.
MedLine Citation:
PMID:  25253629     Owner:  NLM     Status:  Publisher    
BACKGROUND: Moyamoya disease and atherosclerotic cerebrovascular occlusive disease lead to hemodynamic impairment of cerebral blood flow. One major differentiation between both disease entities lies in the collateralization pathways. The clinical implications of the collateralization pathways for the development of hemodynamic ischemia remain unknown. The aim was to characterize collateralization and ischemia patterns in patients with chronic hemodynamic compromise.
METHODS: Hemodynamic compromise was verified using acetazolamide-stimulated xenon-CT or SPECT in 54 patients [30 moyamoya and 24 atherosclerotic cerebrovascular disease (ACVD)]. All patients received MRI to differentiate hemodynamic ischemia into anterior/posterior cortical border zone infarction (CBI), inferior border zone infarction (IBI) or territorial infarction (TI). Digital subtraction angiography was applied to evaluate collateralization. Collateralization was compared and correlated with the localization of ischemia and number of vascular territories with impaired cerebrovascular reserve capacity (CVRC).
RESULTS: MM patients showed collateralization significantly more often via pericallosal anastomosis and the posterior communicating artery (flow in the anterior-posterior direction; MM: 95 %/95 % vs. ACVD: 23 %/12 %, p < 0.05). ACVD patients demonstrated collateralization via the anterior and posterior communicating arteries (flow in the posterior-anterior direction, MM: 6 %/5 % vs. ACVD: 62 %/88 %, p < 0.05). Patterns of infarction were comparable (aCBI: MM: 36 % vs. ACVD: 35 %; pCBI: MM: 10 % vs. ACVD: 20 %; IBI: MM: 35 % vs. ACVD: 41 %; TI: MM: 13 % vs. ACVD: 18 %). The number and localization of vascular territories with impaired CVRC were comparable.
CONCLUSIONS: Despite significant differences in collateralization, the infarct patterns and severity of CVRC impairment do not differ between MMV and ACVD patients. Cerebral collateralization does not allow reaching conclusions about the localization of cerebral ischemia or severity of impaired CVRC in chronic hemodynamic impairment.
Marcus Czabanka; Gueliz Acker; Daniel Jussen; Tobias Finger; Pablo Pena-Tapia; Gerrit A Schubert; Johann Scharf; Peter Martus; Peter Schmiedek; Peter Vajkoczy
Related Documents :
19685519 - Long-term prognosis of non-interventionally followed patients with isolated myocardial ...
2620679 - Dilatation of epicardial coronary arteries and attenuation of provoked coronary vasocon...
7889439 - Aortocoronary vein graft spasm during angiography.
18721599 - Coronary artery spasm: a rare but important cause of postoperative myocardial infarction.
20424449 - First report of the successful use of bosentan in refractory vasospastic angina.
1404849 - Spontaneous coronary artery dissection after a natural course for 10 years--a case report.
11813909 - Living morphogenesis of the ventricles and congenital pathology of their component parts.
471859 - The clinical pathology of heart failure and atrial fibrillation in old age.
17223419 - Usefulness of routine unfractionated heparin infusion following primary percutaneous co...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-9-25
Journal Detail:
Title:  Acta neurochirurgica     Volume:  -     ISSN:  0942-0940     ISO Abbreviation:  Acta Neurochir (Wien)     Publication Date:  2014 Sep 
Date Detail:
Created Date:  2014-9-25     Completed Date:  -     Revised Date:  2014-9-26    
Medline Journal Info:
Nlm Unique ID:  0151000     Medline TA:  Acta Neurochir (Wien)     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Vita tua, mors mea: The experience of family caregivers of patients in a vegetative state.
Next Document:  Cost analysis of voriconazole versus liposomal amphotericin B for primary therapy of invasive asperg...